How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

KROS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $955,800.00

Keros Therapeutics Insider Trading History Chart

Keros Therapeutics Share Price & Price History

^$35.65

▲ +0.14 (0.39%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

Keros Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/8/2023	Keith Regnante	CFO	Sell	20,000	$47.79	$955,800.00
7/15/2022	Jennifer Lachey	Insider	Sell	46,034	$30.00	$1,381,020.00	95,100
7/13/2022	Jennifer Lachey	Insider	Sell	1,916	$30.00	$57,480.00	95,100
5/11/2022	Jennifer Lachey	Insider	Sell	5,300	$41.90	$222,070.00	85,700
4/11/2022	Jennifer Lachey	Insider	Sell	5,300	$62.77	$332,681.00	85,700
4/6/2022	Christopher Rovaldi	COO	Sell	1,728	$65.00	$112,320.00
4/4/2022	Jennifer Lachey	Insider	Sell	7,950	$60.00	$477,000.00	85,700
3/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.38	$141,457.00
2/11/2022	Jennifer Lachey	Insider	Sell	2,650	$52.06	$137,959.00
1/11/2022	Jennifer Lachey	Insider	Sell	2,650	$53.75	$142,437.50
1/5/2022	Jennifer Lachey	Insider	Sell	2,650	$60.00	$159,000.00
1/5/2022	Julius Knowles	Director	Sell	4,034	$58.25	$234,980.50
1/3/2022	Julius Knowles	Director	Sell	23,555	$58.01	$1,366,425.55
12/15/2021	Jennifer Lachey	Insider	Sell	735	$50.00	$36,750.00
12/13/2021	Jennifer Lachey	Insider	Sell	1,915	$50.55	$96,803.25
11/10/2021	Jennifer Lachey	Insider	Sell	15,900	$60.00	$954,000.00
11/3/2021	Julius Knowles	Director	Sell	15,967	$41.95	$669,815.65
11/1/2021	Julius Knowles	Director	Sell	23,803	$42.15	$1,003,296.45
10/20/2021	Julius Knowles	Director	Sell	4,082	$38.24	$156,095.68
10/18/2021	Julius Knowles	Director	Sell	13,786	$37.70	$519,732.20
10/14/2021	Julius Knowles	Director	Sell	4,383	$40.13	$175,889.79
10/4/2021	Julius Knowles	Director	Sell	3,746	$40.06	$150,064.76
10/1/2021	Julius Knowles	Director	Sell	6,323	$40.16	$253,931.68
9/27/2021	Julius Knowles	Director	Sell	95,302	$41.17	$3,923,583.34
7/1/2021	Julius Knowles	Director	Sell	23,834	$41.28	$983,867.52
6/11/2021	Jennifer Lachey	Insider	Sell	2,650	$50.98	$135,097.00	1,000
6/7/2021	Julius Knowles	Director	Sell	12,796	$49.89	$638,392.44
6/3/2021	Julius Knowles	Director	Sell	7,895	$47.97	$378,723.15
6/1/2021	Julius Knowles	Director	Sell	8,812	$52.51	$462,718.12
5/3/2021	Julius Knowles	Director	Sell	44,816	$57.48	$2,576,023.68
4/12/2021	Claudia Ordonez	Insider	Sell	1,000	$59.93	$59,930.00	1,000
4/5/2021	Julius Knowles	Director	Sell	27,151	$60.07	$1,630,960.57
4/1/2021	Julius Knowles	Director	Sell	11,202	$58.89	$659,685.78
3/3/2021	Julius Knowles	Director	Sell	12,327	$57.36	$707,076.72
3/1/2021	Julius Knowles	Director	Sell	12,979	$63.09	$818,845.11
2/18/2021	Julius Knowles	Director	Sell	28,617	$60.87	$1,741,916.79
2/11/2021	Claudia Ordonez	Insider	Sell	1,000	$64.84	$64,840.00	1,000
2/11/2021	Julius Knowles	Director	Sell	11,561	$64.82	$749,384.02

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Keros Therapeutics (NASDAQ:KROS)

75.56% of Keros Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Keros Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	98,109	$3.13M	0.0%	-35.8%	0.327%
11/24/2023	Deutsche Bank AG	12,572	$0.40M	0.0%	-84.8%	0.042%
11/15/2023	The Manufacturers Life Insurance Company	29,874	$0.95M	0.0%	+9.4%	0.100%
11/15/2023	GSA Capital Partners LLP	17,161	$0.55M	0.0%	N/A	0.057%
11/15/2023	Schroder Investment Management Group	7,917	$0.25M	0.0%	N/A	0.026%
11/15/2023	Legal & General Group Plc	18,926	$0.60M	0.0%	+4.6%	0.063%
11/14/2023	Braidwell LP	1,357,309	$43.27M	1.3%	+18.7%	4.531%
11/14/2023	Schonfeld Strategic Advisors LLC	77,800	$2.48M	0.0%	-10.3%	0.260%
11/14/2023	California State Teachers Retirement System	23,267	$0.74M	0.0%	-7.2%	0.078%
11/14/2023	Qube Research & Technologies Ltd	8,958	$0.29M	0.0%	-66.6%	0.030%
11/14/2023	Profund Advisors LLC	10,021	$0.32M	0.0%	-22.5%	0.033%
11/13/2023	CHI Advisors LLC	407,633	$13M	3.9%	+1.4%	1.361%
11/13/2023	Algert Global LLC	10,635	$0.34M	0.0%	-35.9%	0.035%
11/13/2023	Northern Trust Corp	212,899	$6.79M	0.0%	+4.5%	0.711%
11/13/2023	Invesco Ltd.	16,551	$0.53M	0.0%	+48.5%	0.055%
11/13/2023	FMR LLC	3,604,928	$114.93M	0.0%	-11.2%	12.032%
11/13/2023	Rafferty Asset Management LLC	58,189	$1.86M	0.0%	-17.2%	0.194%
11/9/2023	Rhumbline Advisers	32,543	$1.04M	0.0%	-1.2%	0.109%
11/9/2023	Deutsche Bank AG	12,572	$0.40M	0.0%	-84.8%	0.042%
11/9/2023	Citigroup Inc.	98,109	$3.13M	0.0%	-35.8%	0.327%
11/9/2023	UBS Group AG	6,587	$0.21M	0.0%	-77.8%	0.022%
11/8/2023	Charles Schwab Investment Management Inc.	176,953	$5.64M	0.0%	+19.7%	0.597%
11/8/2023	Swiss National Bank	45,600	$1.45M	0.0%	+4.8%	0.154%
11/7/2023	Barclays PLC	49,511	$1.58M	0.0%	+29.0%	0.167%
10/27/2023	TD Asset Management Inc	36,200	$1.15M	0.0%	+100.0%	0.122%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	12,494	$0.40M	0.0%	+8.2%	0.042%
10/24/2023	Bank of New York Mellon Corp	144,409	$4.60M	0.0%	+42.1%	0.487%
10/13/2023	SG Americas Securities LLC	47,183	$1.50M	0.0%	+466.7%	0.159%
10/10/2023	WCM Investment Management LLC	97,542	$3.11M	0.0%	+2.4%	0.329%
8/22/2023	CHI Advisors LLC	402,118	$16.16M	4.9%	+54.0%	1.356%
8/21/2023	California State Teachers Retirement System	25,060	$1.01M	0.0%	+15.6%	0.084%
8/21/2023	Osaic Holdings Inc.	884	$36K	0.0%	N/A	0.003%
8/16/2023	Nuveen Asset Management LLC	51,659	$2.08M	0.0%	-23.1%	0.174%
8/15/2023	Alliancebernstein L.P.	21,120	$0.85M	0.0%	+29.6%	0.071%
8/15/2023	Wells Fargo & Company MN	21,323	$0.86M	0.0%	+49.0%	0.072%
8/15/2023	Eventide Asset Management LLC	580,000	$23.30M	0.4%	+93.3%	1.955%
8/15/2023	Woodline Partners LP	279,701	$11.24M	0.1%	+41.2%	0.943%
8/15/2023	Goldman Sachs Group Inc.	73,907	$2.97M	0.0%	+18.7%	0.249%
8/15/2023	Point72 Asset Management L.P.	349,660	$14.05M	0.0%	+70.0%	1.179%
8/15/2023	Royal Bank of Canada	5,135	$0.21M	0.0%	+114.7%	0.017%
8/15/2023	Kennedy Capital Management LLC	58,119	$2.34M	0.1%	+143.4%	0.196%
8/15/2023	Braidwell LP	1,143,865	$45.96M	1.5%	N/A	3.857%
8/14/2023	Tower Research Capital LLC TRC	1,966	$79K	0.0%	+72.5%	0.007%
8/14/2023	Schonfeld Strategic Advisors LLC	86,727	$3.49M	0.0%	+53.4%	0.292%
8/14/2023	Marshall Wace LLP	62,650	$2.52M	0.0%	-46.2%	0.211%
8/14/2023	State of Wisconsin Investment Board	14,734	$0.59M	0.0%	-17.9%	0.050%
8/14/2023	State Street Corp	1,015,903	$40.82M	0.0%	+7.6%	3.425%
8/14/2023	Nuveen Asset Management LLC	51,659	$2.08M	0.0%	-23.1%	0.174%
8/11/2023	Renaissance Technologies LLC	68,400	$2.75M	0.0%	-43.5%	0.231%
8/11/2023	Credit Suisse AG	26,982	$1.08M	0.0%	+40.0%	0.091%
8/11/2023	BlackRock Inc.	1,744,397	$70.09M	0.0%	+4.0%	5.881%
8/11/2023	Ameritas Investment Partners Inc.	1,859	$75K	0.0%	+31.8%	0.006%
8/11/2023	Campbell & CO Investment Adviser LLC	7,745	$0.31M	0.1%	N/A	0.026%
8/11/2023	B. Metzler seel. Sohn & Co. AG	26,256	$1.06M	0.0%	+113.2%	0.089%
8/11/2023	The Manufacturers Life Insurance Company	27,307	$1.10M	0.0%	+5.9%	0.092%
8/11/2023	Geode Capital Management LLC	420,722	$16.91M	0.0%	+14.3%	1.418%
8/11/2023	JPMorgan Chase & Co.	29,690	$1.19M	0.0%	+26.8%	0.100%
8/11/2023	Northern Trust Corp	203,683	$8.18M	0.0%	+14.9%	0.687%
8/10/2023	MetLife Investment Management LLC	11,885	$0.48M	0.0%	+17.7%	0.040%
8/10/2023	Osaic Holdings Inc.	884	$36K	0.0%	N/A	0.003%
8/10/2023	Profund Advisors LLC	12,935	$0.52M	0.0%	+9.2%	0.044%
8/10/2023	Russell Investments Group Ltd.	68,562	$2.76M	0.0%	+23.3%	0.232%
8/10/2023	Meitav Investment House Ltd.	1,597	$64K	0.0%	N/A	0.005%
8/10/2023	Charles Schwab Investment Management Inc.	147,785	$5.94M	0.0%	+11.3%	0.500%
8/10/2023	Citigroup Inc.	152,847	$6.14M	0.0%	-53.1%	0.517%
8/9/2023	Dimensional Fund Advisors LP	58,766	$2.36M	0.0%	N/A	0.199%
8/9/2023	Swiss National Bank	43,500	$1.75M	0.0%	+21.8%	0.147%
8/8/2023	Rhumbline Advisers	32,953	$1.32M	0.0%	+17.3%	0.111%
8/8/2023	Candriam S.C.A.	721,061	$28.97M	0.2%	-3.2%	2.438%
8/7/2023	Principal Financial Group Inc.	6,612	$0.27M	0.0%	+12.5%	0.022%
8/4/2023	American International Group Inc.	10,834	$0.44M	0.0%	+16.7%	0.037%
8/3/2023	Barclays PLC	38,393	$1.54M	0.0%	+30.8%	0.129%
8/3/2023	Bank of New York Mellon Corp	101,638	$4.08M	0.0%	-23.3%	0.344%
8/2/2023	Handelsbanken Fonder AB	6,700	$0.27M	0.0%	-8.2%	0.023%
8/1/2023	Arizona State Retirement System	5,611	$0.23M	0.0%	+17.2%	0.019%
7/31/2023	Strs Ohio	5,700	$0.23M	0.0%	+7.5%	0.019%
7/27/2023	Virtu Financial LLC	8,708	$0.35M	0.0%	N/A	0.029%
7/24/2023	Allspring Global Investments Holdings LLC	686	$28K	0.0%	-51.7%	0.002%
7/19/2023	Teacher Retirement System of Texas	5,409	$0.22M	0.0%	+6.2%	0.018%
7/18/2023	Allspring Global Investments Holdings LLC	686	$28K	0.0%	-51.7%	0.002%
7/14/2023	WCM Investment Management LLC	95,213	$3.80M	0.0%	+13.3%	0.322%
7/10/2023	SG Americas Securities LLC	8,326	$0.34M	0.0%	-70.3%	0.028%
5/22/2023	Putnam Investments LLC	8,116	$0.35M	0.0%	-3.9%	0.027%
5/18/2023	JPMorgan Chase & Co.	23,420	$1M	0.0%	-43.5%	0.079%
5/18/2023	New York State Common Retirement Fund	10,067	$0.43M	0.0%	-22.9%	0.034%
5/16/2023	Jane Street Group LLC	19,042	$0.81M	0.0%	+342.8%	0.064%
5/16/2023	Sphera Funds Management LTD.	30,119	$1.29M	0.2%	-81.0%	0.102%
5/16/2023	State Street Corp	944,159	$40.32M	0.0%	-2.5%	3.191%
5/16/2023	First Light Asset Management LLC	593,964	$25.36M	2.3%	+0.3%	2.008%
5/16/2023	Geode Capital Management LLC	368,046	$15.72M	0.0%	+5.2%	1.244%
5/16/2023	AQR Capital Management LLC	7,591	$0.32M	0.0%	N/A	0.026%
5/15/2023	Schonfeld Strategic Advisors LLC	56,545	$2.41M	0.0%	+40.3%	0.191%
5/15/2023	Cubist Systematic Strategies LLC	8,306	$0.36M	0.0%	+86.1%	0.028%
5/15/2023	WCM Investment Management LLC	84,026	$3.59M	0.0%	+1.1%	0.284%
5/15/2023	Darwin Global Management Ltd.	31,386	$1.34M	0.4%	-92.7%	0.106%
5/15/2023	Deutsche Bank AG	87,396	$3.73M	0.0%	+663.3%	0.295%
5/15/2023	Price T Rowe Associates Inc. MD	1,152,516	$49.21M	0.0%	+85.5%	3.896%
5/12/2023	Renaissance Technologies LLC	121,100	$5.17M	0.0%	+31.8%	0.409%
5/12/2023	Candriam S.C.A.	745,057	$29.28M	0.2%	+19.0%	2.518%
5/12/2023	BlackRock Inc.	1,677,260	$71.62M	0.0%	+2.4%	5.669%

Data available starting January 2016

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical need in the United States. The company's lead protein therapeutic product candidate KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-047, a small molecule product candidate that is in Phase II clinical trials for the treatment of functional iron deficiency; and KER-012, which is in Phase II clinical trials to treat pulmonary arterial hypertension and cardiovascular disorders. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $35.65

$34.97

$36.85

50 Day Range

MA: $30.28

$27.12

$35.65

52 Week Range

Now: $35.65

$27.02

$59.96

Volume

325,560 shs

Average Volume

249,233 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Keros Therapeutics?: Keros Therapeutics' top insider shareholders include:
Jennifer Lachey (Insider)
Christopher Rovaldi (COO)
Julius Knowles (Director)
Keith Regnante (CFO)
Learn More about top insider investors at Keros Therapeutics.
Who are the major institutional investors of Keros Therapeutics?: Keros Therapeutics' top institutional shareholders include:
FMR LLC — 12.03%
Braidwell LP — 4.53%
CHI Advisors LLC — 1.36%
Northern Trust Corp — 0.71%
Charles Schwab Investment Management Inc. — 0.60%
Bank of New York Mellon Corp — 0.49%
Learn More about top institutional investors of Keros Therapeutics stock.
Which major investors are selling Keros Therapeutics stock?: Within the last quarter, KROS stock was sold by these institutional investors:
FMR LLC
Deutsche Bank AG
Deutsche Bank AG
Citigroup Inc.
Citigroup Inc.
UBS Group AG
Qube Research & Technologies Ltd
Rafferty Asset Management LLC
Which major investors are buying Keros Therapeutics stock?: Within the previous quarter, KROS stock was bought by institutional investors including:
Braidwell LP
Bank of New York Mellon Corp
SG Americas Securities LLC
Charles Schwab Investment Management Inc.
TD Asset Management Inc
GSA Capital Partners LLP
Barclays PLC
Northern Trust Corp